We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > prescribing

News List

FDA encourages appropriate prescribing of opioids europeanpharmaceuticalreview
September 21, 2018
The FDA has updated its Opioid Analgesic REMS to ensure caregivers and patients use opioids effectively…
FDA to Encourage “Appropriate and Rational” Prescribing of Opioids through New Safety Measures americanpharmaceuticalreview
September 20, 2018
The U.S. Food and Drug Administration (FDA) took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).
UK drug advisors recommend rescheduling of medical cannabis pharmatimes
July 23, 2018
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.